Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

April 1, 2025; Volume 66,Issue 4

Discussions with Leaders

  • You have access
    New Approaches in Radiopharmaceutical Development
    John Babich and Lale Kostakoglu
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 487-489; DOI: https://doi.org/10.2967/jnumed.125.269492

The State of the Art

  • Open Access
    Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
    Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet Gray, Leona Knox, Kyle B. Matchett, Connie Peet, Katherine A. Vallis, Hugh J. Wallace, Simon Wan and Mark N. Gaze
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 490-496; DOI: https://doi.org/10.2967/jnumed.124.269121

Is It Really Happening?

  • You have access
    Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?
    Rodney J. Hicks
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 497-499; DOI: https://doi.org/10.2967/jnumed.124.267547

Hot Topics

  • You have access
    From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA
    Shilpa Vijayakumar and Sharmila Dorbala
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 500-501; DOI: https://doi.org/10.2967/jnumed.124.268035

Focus on Molecular Imaging

  • You have access
    Molecular Imaging of Pulmonary Fibrosis
    Margaret B. Allison, Ciprian Catana, Iris Y. Zhou, Peter Caravan and Sydney B. Montesi
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 502-505; DOI: https://doi.org/10.2967/jnumed.124.267852

Special Contribution

  • You have access
    Self-Citation Among Highly Cited Nuclear Medicine and Medical Imaging Researchers
    Malik E. Juweid, Obada Al-leimon, Soud F. Al-Qasem, Ibrahim Aljarah and Yaser Rayyan
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 506-508; DOI: https://doi.org/10.2967/jnumed.124.269357
  • Open Access
    Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
    Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, Carlos Uribe, Abhinav K. Jha, Geoffrey Currie, Joyita Dutta, Georges El-Fakhri, Helena McMeekin, Neeta Pandit-Taskar, Jazmin Schwartz, Kuangyu Shi, Lidia Strigari, Habib Zaidi, Babak Saboury and Arman Rahmim
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 509-515; DOI: https://doi.org/10.2967/jnumed.124.267927

Oncology

  • Clinical

    • Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
      You have access
      Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer
      Pierre Vera, Philippe Giraud, Sébastien Hapdey, Pierrick Gouel, Orianne Jan, Paul Le Roux, Alexandra Langlais, Emilie Lévêque, Florence Le Tinier, Anaïs Olivier, Etienne Martin, Alina Berriolo-Riedinger, Nicolas Pourel, Jean Marc Broglia, Pierre Boisselier, Sophie Guillemard, Naji Salem, Isabelle Brenot-Rossi, Camilo Garcia, Céline Berthold, Etienne Giroux-Leprieur, Damien Moreau, Sophie Guillerm, Khadija Benali, Laurent Tessonnier, Clarisse Audigier-Valette, Delphine Lerouge, Elske Quak, Carole Massabeau, Frédéric Courbon, Maxime Loo, Anne Larrouy, Nadia Ghazzar, Philippe Chaumet-Riffaud, Elodie Amour, Gérard Zalcman, Romain Modzelewski and Sébastien Thureau
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 516-524; DOI: https://doi.org/10.2967/jnumed.124.268499
    • FEATURED CLINICAL INVESTIGATION ARTICLE

      • Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories
        Open Access
        Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories
        Henning Weis, Jasmin Weindler, Katharina Schmidt, Martin Hellmich, Alexander Drzezga and Matthias Schmidt
        Journal of Nuclear Medicine April 1, 2025, 66 (4) 525-530; DOI: https://doi.org/10.2967/jnumed.124.269091
    • PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
      You have access
      PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
      Cristian Udovicich, Mathias Bressel, Jamil Manji, Muhammad Ali, Lewis Au, Arun A. Azad, James P. Buteau, Sarat Chander, David Chang, Renu Eapen, Nathan Lawrentschuk, Sidney M. Levy, Daniel Moon, Declan G. Murphy, Marlon Perera, Mark Shaw, Lavinia Spain, Ben Tran, Michael S. Hofman and Shankar Siva
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 531-536; DOI: https://doi.org/10.2967/jnumed.124.268639
    • [<sup>18</sup>F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry
      You have access
      [18F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry
      Ur Metser, Jelena Lukovic, Aruz Mesci, Pamela MacCrostie, Rosanna Chan, Victor Mak, Lisa Avery, Amit Singnurkar, Deanna L. Langer, Kara Ly and Andres Kohan
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 537-542; DOI: https://doi.org/10.2967/jnumed.124.269289
  • Translational

    • [<sup>99m</sup>Tc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
      You have access
      [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
      Yining Sun, Zhixin Hao, Hannan Gao, Guangjie Yang, Bo Pan, Min Zhu, Yakun Wan, Jiyun Shi, Li Huo, Haojun Chen and Fan Wang
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 543-551; DOI: https://doi.org/10.2967/jnumed.124.268564
  • Basic

    • Development and Preclinical Evaluation of [<sup>64</sup>Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics
      You have access
      Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics
      Xiaoyan Li, You Zhang, Jason C. Mixdorf, Qianyun Wu, Sophia J. Lee, Jonathan W. Engle, Todd E. Barnhart, Shannon C. Kenney, Lixin Rui, Weijun Wei and Weibo Cai
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 552-558; DOI: https://doi.org/10.2967/jnumed.124.268835
    • PET Imaging of PD-L1 Occupancy for Preclinical Assessment of the Efficacy of Combined Anti–PD-L1 Immunotherapy and Targeted Therapy
      You have access
      PET Imaging of PD-L1 Occupancy for Preclinical Assessment of the Efficacy of Combined Anti–PD-L1 Immunotherapy and Targeted Therapy
      Céline Chevaleyre, Léa Zimmermann, Simon Specklin, Dimitri Kereselidze, Alizée Bouleau, Steven Dubois, Hélène Quelquejay, Bernard Maillère, Nicolas Tournier, Hervé Nozach and Charles Truillet
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 559-564; DOI: https://doi.org/10.2967/jnumed.124.268586

Theranostics

  • Clinical

    • Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy
      You have access
      Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy
      Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, Ojaswita Lokre, Steve Y. Cho, Scott B. Perlman, Timothy G. Perk and Robert Jeraj
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 565-571; DOI: https://doi.org/10.2967/jnumed.124.267809
    • Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
      You have access
      Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
      Louise Kostos, James P. Buteau, Grace Kong, Ben Tran, Mohammad B. Haskali, Michael Fahey, Megan Crumbaker, Louise Emmett, Michael S. Hofman and Arun A. Azad
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 572-578; DOI: https://doi.org/10.2967/jnumed.124.269252
    • Therapy-Related Myeloid Neoplasms After [<sup>177</sup>Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
      You have access
      Therapy-Related Myeloid Neoplasms After [177Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series
      Michal Eifer, Duncan E.K. Sutherland, Isaac Goncalves, James P. Buteau, Lewis Au, Arun A. Azad, Louise Emmett, Grace Kong, Louise Kostos, Aravind S. Ravi Kumar, Edmond M. Kwan, Elizabeth Medhurst, Shahneen Sandhu, Ben Tran, Alexander W. Wyatt and Michael S. Hofman
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 579-584; DOI: https://doi.org/10.2967/jnumed.124.268640
    • Comparison of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [<sup>18</sup>F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy
      You have access
      Comparison of [68Ga]Ga-Fibroblast Activation Protein Inhibitor–04 and [18F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical Therapy
      Rongxi Wang, Jiarou Wang, Jialin Xiang, Huimin Sui, Linlin Li, Chenhao Jia, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 585-591; DOI: https://doi.org/10.2967/jnumed.124.268258
  • Basic

    • <sup>225</sup>Ac/<sup>89</sup>Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer
      Open Access
      225Ac/89Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer
      Hanan Babeker, Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen, Alissar Monzer, Anjong Florence Tikum, Alireza Doroudi, Emmanuel Nwangele, Maruti Uppalapati and Humphrey Fonge
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 592-598; DOI: https://doi.org/10.2967/jnumed.124.268387
    • Preclinical Evaluation of <sup>177</sup>Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy
      Open Access
      Preclinical Evaluation of 177Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy
      Caroline Foxton, Bradley Waldron, Rikke Veggerby Grønlund, Jaime (Jim) Simón, Bart Cornelissen, Edward O’Neill and Daniel Stevens
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 599-604; DOI: https://doi.org/10.2967/jnumed.124.268508
    • FEATURED ARTICLE OF THE MONTH

      • IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
        You have access
        IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
        Leah Gajecki, Irina V. Lebedeva, Yu-Rou Liao, Daisy Ambriz, Lukas M. Carter, Melina Kumpf, Samantha Lovibond, Justin S. Hachey, Maya S. Graham, Michael Postow, Jason S. Lewis, David P. Andrew, Manuel Baca, Heiko Schöder, Steven M. Larson, Darren R. Veach and Simone Krebs
        Journal of Nuclear Medicine April 1, 2025, 66 (4) 605-611; DOI: https://doi.org/10.2967/jnumed.124.268762

Neurology

  • Clinical

    • Development and Validation of a <sup>18</sup>F-Flortaucipir PET Visual Stratification Method
      Open Access
      Development and Validation of a 18F-Flortaucipir PET Visual Stratification Method
      Ilke Tunali, Jian Wang, Anupa K. Arora, Min Jung Kim, Sergey Shcherbinin, Michael Pontecorvo and Leonardo Iaccarino
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 612-619; DOI: https://doi.org/10.2967/jnumed.124.268700
    • Imaging Synaptic Density in Aging and Alzheimer Disease with [<sup>18</sup>F]SynVesT-1
      Open Access
      Imaging Synaptic Density in Aging and Alzheimer Disease with [18F]SynVesT-1
      Joseph Giorgio, David N. Soleimani-Meigooni, Mustafa Janabi, Suzanne L. Baker, Xi Chen, Tyler N. Toueg, Robby Weimer, Bastian Zinnhardt, Ari Green, Gil D. Rabinovici and William J. Jagust
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 620-625; DOI: https://doi.org/10.2967/jnumed.124.269005

Cardiovascular

  • Clinical

    • Biodistribution, Safety Profile, and Radiation Dosimetry of [<sup>18</sup>F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects
      You have access
      Biodistribution, Safety Profile, and Radiation Dosimetry of [18F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects
      Juhani Knuuti, Małgorzata Kobylecka, Seweryn Krajewski, Lukasz Steczek, Karina Gotowicz, Joanna Towpik, Kari Kalliokoski, Tuula Tolvanen, Magdalena Kostkiewicz, Przemysław Kozanecki, Joanna Włostowska, Mirosław Dziuk, Leszek Królicki, Jacek Bil, Piotr J. Slomka, Timothy M. Bateman, Mouaz H. Al-Mallah, Panithaya Chareonthaitawee, Prem Soman and Cezary Kozanecki
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 626-633; DOI: https://doi.org/10.2967/jnumed.124.268872

Inflammation/Infection

  • Clinical

    • Differences in Fibroinflammatory Activity Shown on <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease
      You have access
      Differences in Fibroinflammatory Activity Shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease
      Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu and Yaping Luo
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 634-640; DOI: https://doi.org/10.2967/jnumed.124.268943

Radiobiology/Dosimetry

  • Clinical

    • Tumor Dose–Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PET
      You have access
      Tumor Dose–Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
      Alexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, Jochen Schmitz, Christina Laschinsky, Ken Herrmann, Andreas Bockisch, Pedro Fragoso Costa, David Kersting and Walter Jentzen
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 641-647; DOI: https://doi.org/10.2967/jnumed.124.269377

AI/Advanced Image Analysis

  • Clinical

    • Artificial Intelligence–Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion Imaging
      You have access
      Artificial Intelligence–Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion Imaging
      Robert J.H. Miller, Paul Kavanagh, Mark Lemley, Joanna X. Liang, Tali Sharir, Andrew J. Einstein, Mathews B. Fish, Terrence D. Ruddy, Philipp A. Kaufmann, Albert J. Sinusas, Edward J. Miller, Timothy M. Bateman, Sharmila Dorbala, Marcelo Di Carli, Sean Hayes, John Friedman, Daniel S. Berman, Damini Dey and Piotr J. Slomka
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 648-653; DOI: https://doi.org/10.2967/jnumed.124.268079

Physics and Instrumentation

  • Clinical

    • Total-Body Parametric Imaging Using Relative Patlak Plot
      Open Access
      Total-Body Parametric Imaging Using Relative Patlak Plot
      Siqi Li, Yasser G. Abdelhafez, Lorenzo Nardo, Simon R. Cherry, Ramsey D. Badawi and Guobao Wang
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 654-661; DOI: https://doi.org/10.2967/jnumed.124.268496

The Illustrated Post

  • Clinical

    • You have access
      CCK2 Receptor Ligand [68Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [68Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer
      Oliver Viering, Nadine Holzleitner, Rainer Claus, Adriana Amerein, Niklas Dreher, Johanna S. Enke, Alexander Dierks, Christian H. Pfob, Malte Kircher, Veronika Felber, Thomas Günther and Constantin Lapa
      Journal of Nuclear Medicine April 1, 2025, 66 (4) 662; DOI: https://doi.org/10.2967/jnumed.124.269201

Letters to the Editor

  • You have access
    176Lu Radiation Dose of Long–Axial Field of View PET Scanners
    Samaneh Mostafapour, Joyce van Sluis, Adriaan A. Lammertsma and Charalampos Tsoumpas
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 663; DOI: https://doi.org/10.2967/jnumed.124.269187
  • You have access
    The PRIMARY Score: Present and Future
    Linlin Guo and Guohua Shen
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 663-664; DOI: https://doi.org/10.2967/jnumed.124.267898

Department

  • You have access
    Erratum
    Journal of Nuclear Medicine April 1, 2025, 66 (4) 664;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 66 (4)
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
  • Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories
Sign up for alerts

Jump to

  • Discussions with Leaders
  • The State of the Art
  • Is It Really Happening?
  • Hot Topics
  • Focus on Molecular Imaging
  • Special Contribution
  • Oncology
    • Clinical
      • FEATURED CLINICAL INVESTIGATION ARTICLE
    • Translational
    • Basic
  • Theranostics
    • Clinical
    • Basic
      • FEATURED ARTICLE OF THE MONTH
  • Neurology
    • Clinical
  • Cardiovascular
    • Clinical
  • Inflammation/Infection
    • Clinical
  • Radiobiology/Dosimetry
    • Clinical
  • AI/Advanced Image Analysis
    • Clinical
  • Physics and Instrumentation
    • Clinical
  • The Illustrated Post
    • Clinical
  • Letters to the Editor
  • Department
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire